StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report report published on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
Shares of NASDAQ ATHX opened at $0.00 on Friday. The firm has a market cap of $253,047.90, a P/E ratio of 0.00 and a beta of -0.90. Athersys has a 1-year low of $0.01 and a 1-year high of $1.99. The business’s 50 day moving average is $0.01 and its 200-day moving average is $0.02.
About Athersys
Recommended Stories
- Five stocks we like better than Athersys
- What is a Secondary Public Offering? What Investors Need to Know
- AMD is Down 35%. Now is the Time to Buy the Dip
- Bank Stocks – Best Bank Stocks to Invest In
- Amazon Stands Tall: New Highs Are in Sight
- Business Services Stocks Investing
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
